Elective node radiation effective in recurrent prostate cancer, but more toxic
Largest study yet compares the treatment with stereotactic body radiotherapy
Elective nodal radiotherapy appears to reduce relapses more effectively than stereotactic body radiotherapy in men with nodal oligorecurrent prostate cancer, according to a retrospective analysis.
However, elective nodal radiotherapy (ENRT) is also more toxic, researchers report in European Urology.